Transboundary and Emerging Diseases

Research Progress on African Swine Fever Virus


Publishing date
01 Oct 2024
Status
Open
Submission deadline
14 Jun 2024

Lead Editor

1Harbin Veterinary Research Institute, Harbin, China

2The Pirbright Institute, Woking, UK

3Kansas State University, Manhattan, USA

4University of Bern, Bern, Switzerland


Research Progress on African Swine Fever Virus


Call for papers

This Issue is now open for submissions.

Papers are published upon acceptance, regardless of the Special Issue publication date.

 Submit to this Special Issue

Description

African swine fever (ASF), caused by the African swine fever virus (ASFV), is a WOAH-notifiable, acute hemorrhagic and highly contagious disease in domestic pigs and wild boars which poses a major threat to the pig industry and global food security. Currently, this disease is a widespread epidemic in Africa, Europe, Asia and Americas, causing enormous economic losses. ASFV is a complex, large (170-193 Kbp), enveloped, and double-stranded DNA virus, which encodes more than 150 viral proteins. ASFV was first identified in the 1920s, but research on the virus has increased dramatically in these years. Up to date, many scientific questions on ASFV still need to be explored.

Although ASF has emerged over 100 years in the world, there remains some challenges because of complex structure, proteins of unknown function, and emergence of mutations, and recombinant viruses. Some challenges are shown as follows: First, the epidemiology: complex transmission route, including direct contact, indirect contact, food or feed borne transmission, and insect vectors; characteristics of different circulating ASFVs in different regions including whole-genome sequence, virulence, pathogenicity, and transmission capacity. Second, the fundamental research: the mechanism of pathogenesis, immune evasion, and immune protection; the structure and function of viral proteins. Third, the applied research: the diagnostic techniques. The rapid, reliable, specific, sensitive, and convenient etiological or serological diagnostic methods; 2) the safe and effective vaccine. Currently, the attenuated vaccines are the most promising candidate among different vaccine development strategies.

The aim of this Special Issue is to publish the scientific studies on different aspects of ASFV including the epidemiology, diagnostics, control as well as the molecular mechanisms of the pathogenesis, immune evasion, and immune protection, for adopting scientific and reasonable measures to control the spread of the disease worldwide. For this purpose, the manuscripts (but are not limited) associated with ASFV diagnostics, surveillance, vaccines, and control, are especially welcomes. Meanwhile, this Special Issue welcomes original research and reviews articles.

Potential topics include but are not limited to the following:

  • Whole-genome sequence analysis
  • Virulence, replication capacity, and transmissibility in swine
  • Molecular mechanisms of virus infection and pathogenesis
  • Function of ASFV genes
  • Structure of ASFV proteins
  • Novel/improved antigen detection assays
  • Novel/improved nucleic acid detection methods
  • Multiple types of vaccines including inactivated-virus, live attenuated, vector-based, protein-based, and mRNA-based vaccines
  • Mechanism of immune protection against ASFV
  • Antiviral drugs with advanced antiviral actions, antiviral targets, and antiviral mechanisms
  • High-level disinfectants and effective
Transboundary and Emerging Diseases
Publishing Collaboration
More info
Wiley Hindawi logo
 Journal metrics
See full report
Acceptance rate34%
Submission to final decision111 days
Acceptance to publication24 days
CiteScore7.400
Journal Citation Indicator1.450
Impact Factor4.3

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.